Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PEMETREXED ZENTIVA 10 MG/ML SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PEMETREXED ZENTIVA 10 MG/ML SOLUCION PARA PERFUSION

Approved

STANDARD

PEMETREXED ZENTIVA 10 MG/ML SOLUCION PARA PERFUSION

Zentiva K.S.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 12, 2022
Approval ID: a92222ae842903c5
Company: Zentiva K.S.
Type: Standard

Approval Details

Approval Id: a92222ae842903c5
Drug Cima Aemps Name: PEMETREXED ZENTIVA 10 MG/ML SOLUCION PARA PERFUSION
Register Number: 86706
Holder Company Name: Zentiva K.S.
Marketing Company Name: Zentiva Spain S.L.
Holder Company Detail Path: /organization/zentiva-k-s
Authorization Date: 2022-04-12
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 10 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Zentiva K.S.
Company Detail Path: /organization/zentiva-k-s

Company Information

Pharmaceutical Company Name: Zentiva, k.s.
Country Name: Czech Republic
City Name: praha,hlavní město praha,country_cz
Address: U kabelovny 130/22

Active Ingredients

PEMETREXED DISODIO

11,03 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 12, 2022

Approval ID

a92222ae842903c5

Type

Standard

Back to CIMA-AEMPS Approvals